Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 7—July 2013

Letter

Campylobacter jejuni in Hospitalized Patients with Diarrhea, Kolkata, India

Piyali Mukherjee, T. Ramamurthy, Mihir K. Bhattacharya, K. Rajendran, and Asish K. MukhopadhyayComments to Author 
Author affiliations: Author affiliation: National Institute of Cholera and Enteric Diseases, Kolkata, India

Main Article

Figure

Antimicrobial drug susceptibility profile of 142 Campylobacter jejuni isolates, Kolkata, India, 2008–2010. Black bars, resistant; gray bars, intermediate resistance; white bars, susceptible. AMP, ampicillin; NAL, nalidixic acid; NOR, norfloxacin; ERY, erythromycin; GEN, gentamicin; TET, tetracycline; CIP, ciprofloxacin; OFX, ofloxacin; FZD, furazolidone; CHL, chloramphenicol; AZM, azithromycin; STR, streptomycin; TMP–SXT, trimethoprim–sulfamethoxazole.

Figure. . . Antimicrobial drug susceptibility profile of 142 Campylobacter jejuni isolates, Kolkata, India, 2008–2010. Black bars, resistant; gray bars, intermediate resistance; white bars, susceptible. AMP, ampicillin; NAL, nalidixic acid; NOR, norfloxacin; ERY, erythromycin; GEN, gentamicin; TET, tetracycline; CIP, ciprofloxacin; OFX, ofloxacin; FZD, furazolidone; CHL, chloramphenicol; AZM, azithromycin; STR, streptomycin; TMP–SXT, trimethoprim–sulfamethoxazole.

Main Article

TOP